Search Results

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup ana... by Marmé, Frederik (Author) , Martin, M. (Author) , Untch, M. (Author) , Thode, C. (Author) , Bonnefoi, H. (Author) , Kim, S. -B. (Author) , Bear, H. (Author) , Mc Carthy, N. (Author) , Gelmon, K. (Author) , García-Sáenz, J. A. (Author) , Kelly, C. M. (Author) , Reimer, T. (Author) , Valota, O. (Author) , Toi, M. (Author) , Rugo, H. S. (Author) , Gnant, M. (Author) , Makris, A. (Author) , Bassy, M. (Author) , Zhang, Z. (Author) , Furlanetto, J. (Author) , Nekljudova, V. (Author) , Loibl, S. (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Event-free survival in patients with early HER2-positive breast cancer with a pathological complete response after HER2-targeted therapy: a pooled analysis by Swain, Sandra M. (Author) , Macharia, Harrison (Author) , Cortes, Javier (Author) , Dang, Chau (Author) , Gianni, Luca (Author) , Hurvitz, Sara A. (Author) , Jackisch, Christian (Author) , Schneeweiss, Andreas (Author) , Slamon, Dennis (Author) , Valagussa, Pinuccia (Author) , Du Toit, Yolande (Author) , Heinzmann, Dominik (Author) , Knott, Adam (Author) , Song, Chunyan (Author) , Cortazar, Patricia (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Cognition: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy by Pixberg, Constantin Frederic (Author) , Zapatka, Marc (Author) , Hlevnjak, M. (Author) , Benedetto, S. (Author) , Suppelna, J. P. (Author) , Heil, Jörg (Author) , Smetanay, Katharina (Author) , Michel, Laura L. (Author) , Fremd, Carlo (Author) , Körber, V. (Author) , Rübsam, M. (Author) , Buschhorn, Lars (Author) , Heublein, Sabine (Author) , Schäfgen, Benedikt (Author) , Golatta, Michael (Author) , Gomez, C. (Author) , Au, Alexandra von (Author) , Wallwiener, Markus (Author) , Wolf, Sebastian Immanuel (Author) , Dikow, Nicola (Author) , Schaaf, Christian P. (Author) , Gutjahr, Ewgenija (Author) , Allgäuer, Michael (Author) , Stenzinger, Albrecht (Author) , Pfütze, K. (Author) , Kirsten, R. (Author) , Hübschmann, Daniel (Author) , Sinn, Peter (Author) , Jäger, Dirk (Author) , Trumpp, Andreas (Author) , Schlenk, Richard Friedrich (Author) , Höfer, Thomas (Author) , Thewes, V. (Author) , Schneeweiss, Andreas (Author) , Lichter, Peter (Author) ,


    Get full text
    Article (Journal) Online Resource
  4. 4

    Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study by Perez-Garcia, Jose Manuel (Author) , Gebhart, Geraldine (Author) , Borrego, Manuel Ruiz (Author) , Schmid, Peter (Author) , Marmé, Frederik (Author) , Prat, Aleix (Author) , Dalenc, Florence (Author) , Kerrou, Khaldoun (Author) , Colleoni, Marco (Author) , Braga, Sofía (Author) , Malfettone, Andrea (Author) , Sampayo-Cordero, Miguel (Author) , Cortés, Javier (Author) , Llombart-Cussac, Antonio (Author) ,


    Get full text
    Article (Journal) Online Resource
  5. 5

    Sacituzumab govitecan: past, present and future of a new antibody-drug conjugate and future horizon: drug evaluation by Furlanetto, Jenny (Author) , Marmé, Frederik (Author) , Loibl, Sibylle (Author) ,


    Get full text
    Article (Journal) Online Resource
  6. 6

    Time trends of neoadjuvant chemotherapy for early breast cancer by Riedel, Fabian (Author) , Hoffmann, Ann Sophie (Author) , Moderow, Mareike (Author) , Heublein, Sabine (Author) , Deutsch, Thomas M. (Author) , Golatta, Michael (Author) , Wallwiener, Markus (Author) , Schneeweiss, Andreas (Author) , Heil, Jörg (Author) , Hennigs, André (Author) ,


    Get full text
    Article (Journal) Online Resource
  7. 7

    A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breas... by Minckwitz, Gunter von (Author) , Conrad, Bettina (Author) , Reimer, Toralf (Author) , Decker, Thomas (Author) , Eidtmann, Holger (Author) , Eiermann, Wolfgang (Author) , Hackmann, John (Author) , Möbus, Volker (Author) , Marmé, Frederik (Author) , Potenberg, Jochem (Author) , Stickeler, Elmar (Author) , Simon, Eike (Author) , Thomssen, Christoph (Author) , Huober, Jens (Author) , Denkert, Carsten (Author) , Alfer, Joachim (Author) , Jackisch, Christian (Author) , Nekljudova, Valentina (Author) , Burchardi, Nicole (Author) , Loibl, Sibylle (Author) ,


    Get full text
    Article (Journal) Online Resource
  8. 8

    Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early brea... by Schneeweiss, Andreas (Author) , Chia, S. (Author) , Hickish, T. (Author) , Harvey, V. (Author) , Eniu, A. (Author) , Hegg, R. (Author) , Tausch, C. (Author) , Seo, J. H. (Author) , Tsai, Y. -F. (Author) , Ratnayake, J. (Author) , McNally, V. (Author) , Ross, G. (Author) , Cortés, J. (Author) ,


    Get full text
    Article (Journal) Online Resource
  9. 9

    A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early br... by Schneeweiss, Andreas (Author) , Marmé, Frederik (Author) , Ruiz, A. (Author) , Manikhas, A. G. (Author) , Bottini, A. (Author) , Wolf, M. (Author) , Sinn, Peter (Author) , Mansouri, K. (Author) , Kennedy, L. (Author) , Bauknecht, T. (Author) ,


    Get full text
    Article (Journal) Online Resource